Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 8, Issue 5, Pages 527-544
Publisher
Future Science, LTD
Online
2016-04-20
DOI
10.4155/fmc.16.7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new ruthenium cyclopentadienyl azole compound with activity on tumor cell lines and trypanosomatid parasites
- (2015) Esteban Rodríguez Arce et al. JOURNAL OF COORDINATION CHEMISTRY
- Comparative solution equilibrium studies on pentamethylcyclopentadienyl rhodium complexes of 2,2ʹ-bipyridine and ethylenediamine and their interaction with human serum albumin
- (2015) Éva A. Enyedy et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compounds
- (2015) Leonor Côrte-Real et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes
- (2014) Leonor Côrte-Real et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Multifaceted interplay between lipophilicity, protein interaction and luminescence parameters of non-intercalative ruthenium(II) polypyridyl complexes controlling cellular imaging and cytotoxic properties
- (2014) Olga Mazuryk et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- New iron(II) cyclopentadienyl derivative complexes: Synthesis and antitumor activity against human leukemia cancer cells
- (2014) Andreia Valente et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- Binding of transition metal ions to albumin: Sites, affinities and rates
- (2013) Wojciech Bal et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Screening organometallic binuclear thiosemicarbazone ruthenium complexes as potential anti-tumour agents: cytotoxic activity and human serum albumin binding mechanism
- (2013) Bruno Demoro et al. DALTON TRANSACTIONS
- Biological activity and cellular uptake of [Ru(η5-C5H5)(PPh3)(Me2bpy)][CF3SO3] complex
- (2013) Tânia S. Morais et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Important cytotoxicity of novel iron(II) cyclopentadienyl complexes with imidazole based ligands
- (2013) Ana Cristina Gonçalves et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- First polymer “ruthenium-cyclopentadienyl” complex as potential anticancer agent
- (2013) Andreia Valente et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Exploring the effect of the ligand design on the interactions between [Ru(η5-C5H5)(PPh3)(N,O)][CF3SO3] complexes and human serum albumin
- (2013) Tânia S. Morais et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- New water-soluble ruthenium(II) cytotoxic complex: Biological activity and cellular distribution
- (2013) Tânia S. Morais et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Opening the lid on piano-stool complexes: An account of ruthenium(II)–arene complexes with medicinal applications
- (2013) Alexey A. Nazarov et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- Cellular Uptake Mechanisms of an Antitumor Ruthenium Compound: The Endosomal/Lysosomal System as a Target for Anticancer Metal-Based Drugs
- (2013) Leonor Côrte-Real et al. MICROSCOPY AND MICROANALYSIS
- Induction of caspase 8 and reactive oxygen species by ruthenium-derived anticancer compounds with improved water solubility and cytotoxicity
- (2012) Vania Vidimar et al. BIOCHEMICAL PHARMACOLOGY
- Designing organometallic compounds for catalysis and therapy
- (2012) Anna Louisa Noffke et al. CHEMICAL COMMUNICATIONS
- VIVO and CuII complexation by ligands based on pyridine nitrogen donors
- (2012) Daniele Sanna et al. DALTON TRANSACTIONS
- Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications
- (2012) Randall Logan et al. Expert Opinion on Drug Metabolism & Toxicology
- New polydentate Ru(III)-Salan complexes: Synthesis, characterization, anti-tumour activity and interaction with human serum proteins
- (2012) Cristina P. Matos et al. INORGANICA CHIMICA ACTA
- Characterization of the binding sites of the anticancer ruthenium(III) complexes KP1019 and KP1339 on human serum albumin via competition studies
- (2012) Orsolya Dömötör et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Synthesis of organometallic ruthenium(II) complexes with strong activity against several human cancer cell lines
- (2012) Tânia S. Morais et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- [RuII(η5-C5H5)(bipy)(PPh3)]+, a promising large spectrum antitumor agent: Cytotoxic activity and interaction with human serum albumin
- (2012) Ana Isabel Tomaz et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Synthesis, Characterization, and in Vitro Studies of Bis[1,3-diethyl-4,5-diarylimidazol-2-ylidene]gold(I/III) Complexes
- (2012) Wukun Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mitaplatin Increases Sensitivity of Tumor Cells to Cisplatin by Inducing Mitochondrial Dysfunction
- (2012) Xue Xue et al. MOLECULAR PHARMACEUTICS
- Gas-phase behaviour of Ru(II) cyclopentadienyl-derived complexes with N-coordinated ligands by electrospray ionization mass spectrometry: fragmentation pathways and energetics
- (2012) Paulo J. Amorim Madeira et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Approaching tumour therapy beyond platinum drugs
- (2011) A. Bergamo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Human serum albumin: From bench to bedside
- (2011) Gabriella Fanali et al. MOLECULAR ASPECTS OF MEDICINE
- Ruthenium-based chemotherapeutics: are they ready for prime time?
- (2010) Emmanuel S. Antonarakis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Transport of Therapeutic Vanadium and Ruthenium Complexes by Blood Plasma Components
- (2010) J. Costa Pessoa et al. CURRENT MEDICINAL CHEMISTRY
- New ruthenium(II) mixed metallocene derived complexes: Synthesis, characterization by X-ray diffraction and evaluation on DNA interaction by atomic force microscopy
- (2010) M. Helena Garcia et al. INORGANICA CHIMICA ACTA
- DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligands
- (2010) Virtudes Moreno et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Organometallic Anticancer Compounds
- (2010) Gilles Gasser et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploring the cellular accumulation of metal complexes
- (2009) Cindy A. Puckett et al. DALTON TRANSACTIONS
- Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model
- (2009) E. Allard et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands
- (2009) M. Helena Garcia et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model
- (2009) A. Bergamo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Toward the Development of a Potent and Selective Organoruthenium Mammalian Sterile 20 Kinase Inhibitor
- (2009) Ruchi Anand et al. JOURNAL OF MEDICINAL CHEMISTRY
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
- (2008) Felix Kratz JOURNAL OF CONTROLLED RELEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More